ReviewClinical microbiology reviews2025
Extrapolation and comparison of West Nile virus- and Usutu virus-associated neurological diseases in humans: linking pathology to clinical symptoms.
Review in Clinical microbiology reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- West Nile virus: epidemiology, prevention, clinical features, diagnosis, treatment, and open research questions.Annals of medicine · 2026Review
- Prevalence and characterization of West Nile virus infections among people living with HIV in Northern Italy: a sero-repository analysis.Infection · 2026Article
- Increased incidence of human West Nile and Usutu infections in Austria, 2024: analysis of data from 2009 to 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
SUMMARYMosquito-borne orthoflaviviruses pose an ever-increasing risk to public health. A prime example is West Nile virus (WNV), which continues to expand its geographical distribution, leading to new outbreaks of severe disease in humans and animals. In contrast, the closely related Usutu virus (USUV) has rarely been associated with neurological disease despite its wide distribution in Europe where human cases of WNV-associated disease largely outnumber those of USUV. Thus, the risk to human health posed by USUV appears to be lower compared with WNV. However, considering their close relation and similarities in ecology, it is still not known why the clinical impact differs for these viruses. In this review, we explore the potential pathogenesis of USUV in human infection by comparing the clinical presentations reported in the few cases of USUV-associated disease with the extensive clinical and pathological data available for WNV. With such a comparison, we aim to determine the clinical significance of USUV and identify key differences between WNV and USUV, which could explain the disparity in the incidence of neurological disease. We identify that while the clinical reports of USUV infection do indicate involvement of similar brain regions as WNV, clinical presentations are not as severe and not as frequent and do not seem to progress to the same extent as many cases of WNV-related neuroinvasive disease. Additionally, we highlight the urgent need to standardize reporting of (arbo)viral meningoencephalitis cases to allow for a better comparison and understanding of viral pathogenesis and the risks posed by new and emerging arboviruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.